Heather Dworak

Heather Dworak

Company: Sunovion

Job title: Senior Director, Clinical Research

Seminars:

Live Q&A 1:20 pm

Read more

day: Day One

Development of SEP-363856, a TAAR1/5-HT1A Agonist for the Treatment of Schizophrenia 11:50 am

• Summary of the discovery of SEP-363856 and its novel non-D2 based mechanism of action for the treatment of schizophrenia • Rationale for development of a non-D2 agent for the treatment of schizophrenia: importance and implications • Overview of clinical trial data to date, and status update of our Phase 3 clinical development programRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.